Are There Biomarkers Based on Phospholipids for Cancer Diagnosis?
Altered phospholipid profiles in cancer cells can serve as biomarkers for diagnosis and prognosis. Techniques like mass spectrometry and lipidomics can analyze the phospholipid composition of biological samples, potentially identifying cancer-specific lipid signatures. These biomarkers can aid in early detection and monitoring of treatment responses.
